CIK 0001820190 · <br>Emerging growth company
Scilex Holding Co
Sign in to watch- Ticker
- SCLX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 516-4310
- Business address
- 960 SAN ANTONIO ROAD, PALO ALTO, CA, 94303
- Former names
- Scilex Holding Company/DE, Vickers Vantage Corp. I
Securities
- SCLX Common Stock Nasdaq
- SCLXW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-17 | Thompson Tommy G Director | Grant or award · Nonstatutory Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2023-01-17 | Lee Tien-Li Director | Grant or award · Nonstatutory Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2023-01-17 | Hamill Laura Director | Grant or award · Nonstatutory Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2023-01-17 | Lemus David Director | Grant or award · Nonstatutory Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2023-01-17 | CZEREPAK ELIZABETH See Remarks | Grant or award · Nonstatutory Stock Option (right to buy) | +350,000 | 350,000 | ||
| 2023-01-17 | SHAH JAISIM See Remarks | Grant or award · Nonstatutory Stock Option (right to buy) | +1,700,000 | 1,700,000 | ||
| 2023-01-17 | Ji Henry Executive Chairperson | Grant or award · Nonstatutory Stock Option (right to buy) | +9,000,000 | 9,000,000 | ||
| 2022-12-02 | Sorrento Therapeutics, Inc. 10% owner | Purchase · Warrants to Purchase Common Stock | +224,841 | $0.35 | $79K | 4,490,617 |
| 2022-11-25 | Sorrento Therapeutics, Inc. 10% owner | Purchase · Warrants to Purchase Common Stock | +46,172 | $0.44 | $20K | 4,265,776 |
| 2022-11-23 | Sorrento Therapeutics, Inc. 10% owner | Purchase · Warrants to Purchase Common Stock | +442,829 | $0.40 | $176K | 4,219,604 |
| 2022-11-22 | Sorrento Therapeutics, Inc. 10% owner | Purchase · Warrants to Purchase Common Stock | +672,775 | $0.23 | $152K | 3,776,775 |
| 2022-11-10 | Vickers Venture Fund VI Pte Ltd 10% owner | Other disposition · Warrants | −5,261,840 | 901,000 | ||
| 2022-11-10 | Vickers Venture Fund VI Pte Ltd 10% owner | Other disposition · Warrants | −578,160 | 99,000 | ||
| 2022-11-10 | Sorrento Therapeutics, Inc. 10% owner | Other acquisition · Warrant to Purchase Common Stock | +2,796,704 | 2,796,704 | ||
| 2022-11-10 | Sorrento Therapeutics, Inc. 10% owner | Other acquisition · Warrant to Purchase Common Stock | +307,296 | 3,104,000 |
Page 4 of 4 · 75 trades